CIK 0002020932
- Non-accelerated filer
- Emerging growth company
AgomAb Therapeutics NV
Sign in to watch- Ticker
- AGMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Belgium
- Entity type
- Other
- Phone
- +32 33023530
- Business address
- POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600
- Open-market buys, last 90 days
- $619,999
- in 8 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$619,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-06 | Knotnerus Tim Jasper Chief Executive Officer | Purchase | +5,000 | $8.70 | $44K | 21,823 |
| 2026-10-05 | Knotnerus Tim Jasper Chief Executive Officer | Purchase | +6,000 | $8.48 | $51K | 16,823 |
Page 1 of 1 · 2 trades